NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

搭配診斷的全球市場:2025年為止的預測與市場機會

Global Companion Diagnostic Market By Technology, By Products, By Indication, By End-User, By Application, By Region, Competition, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 938721
出版日期 內容資訊 英文 119 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

搭配診斷的全球市場:2025年為止的預測與市場機會 Global Companion Diagnostic Market By Technology, By Products, By Indication, By End-User, By Application, By Region, Competition, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 119 Pages
簡介

全球搭配診斷市場規模在2019年估算為30億美元,在預測期間內預計將以驚人的年複合成長率成長。

本報告提供各市場區隔和各地區的全球搭配診斷市場調查,提供市場規模及市場佔有率的預測,推動因素與課題,市場趨勢,競爭情形,企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 全球搭配診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術(基因表現分析,次世代定序,In-Situ雜合反應,免疫組織化學等)
    • 各產品(設備,套件,化驗)
    • 各前兆(腫瘤學,呼吸系統,整形外科,其他)
    • 各終端用戶(醫藥·生物技術企業、 研究所,臨床研究委外機構等)
    • 各用途(藥物研發,體外診斷,其他)
    • 各公司
    • 各地區
  • 市場魅力指數

第5章 亞太地區的搭配診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術
    • 各產品
    • 各前兆
    • 各終端用戶
    • 各用途
    • 各國
  • 市場魅力指數
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 澳洲

第6章 歐洲的搭配診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術
    • 各產品
    • 各前兆
    • 各終端用戶
    • 各用途
    • 各國
  • 市場魅力指數
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利

第7章 北美的搭配診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術
    • 各產品
    • 各前兆
    • 各終端用戶
    • 各用途
    • 各國
  • 市場魅力指數
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第8章 南美的搭配診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術
    • 各產品
    • 各前兆
    • 各終端用戶
    • 各用途
    • 各國
  • 市場魅力指數
  • 南美:國家分析
    • 巴西做
    • 阿根廷
    • 哥倫比亞

第9章 中東·非洲的搭配診斷市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術
    • 各產品
    • 各前兆
    • 各終端用戶
    • 各用途
    • 各國
  • 市場魅力指數
  • 中東·非洲:國家分析
    • 南非
    • 沙烏地阿拉伯
    • UAE

第10章 市場動態

  • 促進因素
  • 課題

第11章 市場趨勢與發展

第12章 競爭情形

  • 競爭的展望
  • 主要企業簡介
    • NG Biotech
    • Agilent Technologies
    • Illumnia
    • Qiagen
    • Thermo Fisher Scientific
    • Roche
    • Molecular MD
    • Myriad Genetics
    • Foundation Medicine
    • Bayer
    • Genentech
    • Abbott
    • Novartis
    • Perkin Elmer
    • Luminex Corporation
    • Parexel
    • Quest Diagnostics
    • Genesys Diagnostics
    • Danaher
    • Siemens Healthcare
    • Biomerieux SA

第13章 策略性推薦事項

第14章 免責聲明

目錄
Product Code: 4536

Global companion diagnostic market size was valued at USD3 billion in 2019 and projected to grow at an impressive CAGR during the forecast period. The key factor responsible for the growth of companion diagnostic market is growing cases of cancer across the globe. Additionally, increase in requirement for targeted therapy is another major factor which is anticipated to bode well for the growth of companion diagnostic market in the coming years. Moreover, rising number of clinical trials is further anticipated to bolster the market growth until 2025.

The global companion diagnostic market is segmented based on technology, products, indication, end-user, application, and region. Based on end user, the market can be segmented into pharmaceutical & biotechnology companies, research laboratories, contract research organization and others. Out of which, the pharmaceutical & biotechnology companies dominated the market in terms of largest market share until 2019 and is further anticipated to be the fastest-growing application segment in the companion diagnostic market during the next five years as well. This growth can be accredited to widespread use of companion diagnostics in such industries because of their increasing stronghold in drug development sector as well as growing importance of companion diagnostic biomarkers. Additionally, surge in requirement for personalized medicines coupled with high demand for targeted therapies for treatment of multiple diseases and disorders is further boosting the growth of the segment across the globe.

Major players operating in the global companion diagnostic market include NG Biotech, Agilent Technologies, Illumnia, Qiagen, Thermo Fisher Scientific, Roche, Molecular MD, Myriad Genetics, Foundation Medicine, Bayer, Genentech, Abbott, Novartis, Perkin Elmer, Luminex Corporation, Parexel, Quest Diagnostics, Genesys Diagnostics, Danaher, Siemens Healthcare, Biomerieux SA and others. The companies operating in global companion diagnostic market are focussing towards expanding their share in the market. For instance, these key players are making organic strategies such as new product launches & approvals, among others in order to enrich their consumer base.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyse and forecast the market size of global companion diagnostic market.
  • To classify and forecast global companion diagnostic market based on technology, products, indication, end-user, application, company and regional distribution.
  • To identify drivers and challenges for global companion diagnostic market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global companion diagnostic market.
  • To conduct pricing analysis for global companion diagnostic market.
  • To identify and analyse the profile of leading players operating in global companion diagnostic market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, technologies and presence of all major players across the globe.

TechSci Research calculated the market size of global companion diagnostic market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Companion diagnostic hospitals/clinics, research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to companion diagnostic
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global companion diagnostic market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technology:

Nanostring Technology

Next-Generation sequencing

In-Situ Hybridization

Immunohistochemistry

Others

  • Market, By Products:

Devices

Kits

Assay

  • Market, By Indication:

Oncology

Respiratory

Orthopedics

Others

  • Market, By End-User:

Pharmaceutical & Biotechnology Companies

Research Laboratories

Contract research organization

Others

  • Market, By Application:

Drug Discovery

In-Vitro diagnostics

Others

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East and Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global companion diagnostic market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Companion Diagnostic Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value & Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Technology (Nanostring Technology, Next-Generation sequencing, In-Situ Hybridization, Immunohistochemistry and Others)
    • 4.2.2. By Products (Devices, Kits and assay)
    • 4.2.3. By Indication (Oncology, Respiratory, Orthopedics and Others)
    • 4.2.4. By End-User (Pharmaceutical & Biotechnology Companies, Research Laboratories, Contract research organization and others)
    • 4.2.5. By Application (Drug Discovery, In-Vitro diagnostics and Others)
    • 4.2.6. By Company (2019)
    • 4.2.7. By Region
  • 4.3. Market Attractiveness Index

5. Asia-Pacific Companion Diagnostic Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology
    • 5.2.2. By Products
    • 5.2.3. By Indication
    • 5.2.4. By End-User
    • 5.2.5. By Application
    • 5.2.6. By Country
  • 5.3. Market Attractiveness Index
  • 5.4. Asia-Pacific: Country Analysis
    • 5.4.1. China Companion Diagnostic Market Outlook
      • 5.4.1.1. Market Size & Forecast
        • 5.4.1.1.1. By Value
      • 5.4.1.2. Market Share & Forecast
        • 5.4.1.2.1. By Technology
        • 5.4.1.2.2. By Products
        • 5.4.1.2.3. By Indication
        • 5.4.1.2.4. By End-User
        • 5.4.1.2.5. By Application
    • 5.4.2. India Companion Diagnostic Market Outlook
      • 5.4.2.1. Market Size & Forecast
        • 5.4.2.1.1. By Value
      • 5.4.2.2. Market Share & Forecast
        • 5.4.2.2.1. By Technology
        • 5.4.2.2.2. By Products
        • 5.4.2.2.3. By Indication
        • 5.4.2.2.4. By End-User
        • 5.4.2.2.5. By Application
    • 5.4.3. Japan Companion Diagnostic Market Outlook
      • 5.4.3.1. Market Size & Forecast
        • 5.4.3.1.1. By Value
      • 5.4.3.2. Market Share & Forecast
        • 5.4.3.2.1. By Technology
        • 5.4.3.2.2. By Products
        • 5.4.3.2.3. By Indication
        • 5.4.3.2.4. By End-User
        • 5.4.3.2.5. By Application
    • 5.4.4. South Korea Companion Diagnostic Market Outlook
      • 5.4.4.1. Market Size & Forecast
        • 5.4.4.1.1. By Value
      • 5.4.4.2. Market Share & Forecast
        • 5.4.4.2.1. By Technology
        • 5.4.4.2.2. By Products
        • 5.4.4.2.3. By Indication
        • 5.4.4.2.4. By End-User
        • 5.4.4.2.5. By Application
    • 5.4.5. Singapore Companion Diagnostic Market Outlook
      • 5.4.5.1. Market Size & Forecast
        • 5.4.5.1.1. By Value
      • 5.4.5.2. Market Share & Forecast
        • 5.4.5.2.1. By Technology
        • 5.4.5.2.2. By Products
        • 5.4.5.2.3. By Indication
        • 5.4.5.2.4. By End-User
        • 5.4.5.2.5. By Application
    • 5.4.6. Australia Companion Diagnostic Market Outlook
      • 5.4.6.1. Market Size & Forecast
        • 5.4.6.1.1. By Value
      • 5.4.6.2. Market Share & Forecast
        • 5.4.6.2.1. By Technology
        • 5.4.6.2.2. By Products
        • 5.4.6.2.3. By Indication
        • 5.4.6.2.4. By End-User
        • 5.4.6.2.5. By Application

6. Europe Companion Diagnostic Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Products
    • 6.2.3. By Indication
    • 6.2.4. By End-User
    • 6.2.5. By Application
    • 6.2.6. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Europe: Country Analysis
    • 6.4.1. France Companion Diagnostic Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Technology
        • 6.4.1.2.2. By Products
        • 6.4.1.2.3. By Indication
        • 6.4.1.2.4. By End-User
        • 6.4.1.2.5. By Application
    • 6.4.2. Germany Companion Diagnostic Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Technology
        • 6.4.2.2.2. By Products
        • 6.4.2.2.3. By Indication
        • 6.4.2.2.4. By End-User
        • 6.4.2.2.5. By Application
    • 6.4.3. United Kingdom Companion Diagnostic Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Technology
        • 6.4.3.2.2. By Products
        • 6.4.3.2.3. By Indication
        • 6.4.3.2.4. By End-User
        • 6.4.3.2.5. By Application
    • 6.4.4. Italy Companion Diagnostic Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Technology
        • 6.4.4.2.2. By Products
        • 6.4.4.2.3. By Indication
        • 6.4.4.2.4. By End-User
        • 6.4.4.2.5. By Application

7. North America Companion Diagnostic Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Products
    • 7.2.3. By Indication
    • 7.2.4. By End-User
    • 7.2.5. By Application
    • 7.2.6. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. North America: Country Analysis
    • 7.4.1. United States Companion Diagnostic Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Technology
        • 7.4.1.2.2. By Products
        • 7.4.1.2.3. By Indication
        • 7.4.1.2.4. By End-User
        • 7.4.1.2.5. By Application
    • 7.4.2. Mexico Companion Diagnostic Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Technology
        • 7.4.2.2.2. By Products
        • 7.4.2.2.3. By Indication
        • 7.4.2.2.4. By End-User
        • 7.4.2.2.5. By Application
    • 7.4.3. Canada Companion Diagnostic Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Technology
        • 7.4.3.2.2. By Products
        • 7.4.3.2.3. By Indication
        • 7.4.3.2.4. By End-User
        • 7.4.3.2.5. By Application

8. South America Companion Diagnostic Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Products
    • 8.2.3. By Indication
    • 8.2.4. By End-User
    • 8.2.5. By Application
    • 8.2.6. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. South America: Country Analysis
    • 8.4.1. Brazil Companion Diagnostic Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Technology
        • 8.4.1.2.2. By Products
        • 8.4.1.2.3. By Indication
        • 8.4.1.2.4. By End-User
        • 8.4.1.2.5. By Application
    • 8.4.2. Argentina Companion Diagnostic Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Technology
        • 8.4.2.2.2. By Products
        • 8.4.2.2.3. By Indication
        • 8.4.2.2.4. By End-User
        • 8.4.2.2.5. By Application
    • 8.4.3. Colombia Companion Diagnostic Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Technology
        • 8.4.3.2.2. By Products
        • 8.4.3.2.3. By Indication
        • 8.4.3.2.4. By End-User
        • 8.4.3.2.5. By Application

9. Middle East and Africa Companion Diagnostic Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Products
    • 9.2.3. By Indication
    • 9.2.4. By End-User
    • 9.2.5. By Application
    • 9.2.6. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. MEA: Country Analysis
    • 9.4.1. South Africa Companion Diagnostic Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Technology
        • 9.4.1.2.2. By Products
        • 9.4.1.2.3. By Indication
        • 9.4.1.2.4. By End-User
        • 9.4.1.2.5. By Application
    • 9.4.2. Saudi Arabia Companion Diagnostic Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Technology
        • 9.4.2.2.2. By Products
        • 9.4.2.2.3. By Indication
        • 9.4.2.2.4. By End-User
        • 9.4.2.2.5. By Application
    • 9.4.3. UAE Companion Diagnostic Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Technology
        • 9.4.3.2.2. By Products
        • 9.4.3.2.3. By Indication
        • 9.4.3.2.4. By End-User
        • 9.4.3.2.5. By Application

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape

  • 12.1. Competition Outlook
  • 12.2. Players Profiled (Leading Companies)
    • 12.2.1. NG Biotech
    • 12.2.2. Agilent Technologies
    • 12.2.3. Illumnia
    • 12.2.4. Qiagen
    • 12.2.5. Thermo Fisher Scientific
    • 12.2.6. Roche
    • 12.2.7. Molecular MD
    • 12.2.8. Myriad Genetics
    • 12.2.9. Foundation Medicine
    • 12.2.10. Bayer
    • 12.2.11. Genentech
    • 12.2.12. Abbott
    • 12.2.13. Novartis
    • 12.2.14. Perkin Elmer
    • 12.2.15. Luminex Corporation
    • 12.2.16. Parexel
    • 12.2.17. Quest Diagnostics
    • 12.2.18. Genesys Diagnostics
    • 12.2.19. Danaher
    • 12.2.20. Siemens Healthcare
    • 12.2.21. Biomerieux SA

13. Strategic Recommendations

14. About Us & Disclaimer